Drug recall · August 18, 2021
Ethosuximide Oral Solution USP 250 mg/5 mL recall
Why: Lack of CGMP: This recall is being carried out due to potential for carry over of Senna Syrup.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Ethosuximide Oral Solution USP 250 mg/5 mL, 16 fl oz (473 mL), Rx ONLY, Pharmaceutical Associates, Inc. Greenville, SC 29605, NDC 0121-0670-16
- Lots / codes
Lot: C9BC Exp. 31OCT2022
- Quantity
- 75 cases (6 bottles/case)
- Company
- PAI Holdings, LLC. dba Pharmaceutical Associates Inc, Greenville, SC
- Distribution
- Distributed Nationwide in the USA
- Initiated
- July 29, 2021 · Voluntary: Firm initiated
- Classified
- August 12, 2021
- Reported
- August 18, 2021
- Ended
- December 2, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Ethosuximide
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.